These compounds may interact with:
Glycogen phosphorylase, liver form
Potentially involved in: glycogen storage disease; glycogen storage disease vi; lymphoid leukemia; kidney cancer; carcinoma; glycogen storage disease type vi; hepatomegaly; hyperlipidemia; hypoglycemia; short stature; increased liver glycogen content; postnatal growth retardation; liver carcinoma; autosomal recessive predisposition; glycogen storage disease 6; adrenocortical carcinoma; adult high grade glioma; astrocytoma, pilocytic; breast carcinoma; ductal carcinoma in situ
Disease data sourced from Pharos.